ID   PLCB4_RAT               Reviewed;        1175 AA.
AC   Q9QW07; O88356; Q9Z0G6;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305};
DE            EC=3.1.4.11 {ECO:0000250|UniProtKB:Q07722};
DE   AltName: Full=Phosphoinositide phospholipase C-beta-4;
DE   AltName: Full=Phospholipase C-beta-4;
DE            Short=PLC-beta-4;
GN   Name=Plcb4 {ECO:0000312|RGD:3345};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8407970; DOI=10.1016/s0021-9258(19)36926-1;
RA   Lee C.-W., Park D.J., Lee K.-H., Kim C.G., Rhee S.G.;
RT   "Purification, molecular cloning, and sequencing of phospholipase C-beta
RT   4.";
RL   J. Biol. Chem. 268:21318-21327(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7688223; DOI=10.1006/bbrc.1993.1879;
RA   Kim M.J., Bahk Y.Y., Min D.S., Lee S.J., Ryu S.H., Suh P.G.;
RT   "Cloning of cDNA encoding rat phospholipase C-beta 4, a new member of the
RT   phospholipase C.";
RL   Biochem. Biophys. Res. Commun. 194:706-712(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 447-1175 (ISOFORM C).
RC   TISSUE=Brain;
RX   PubMed=9931434; DOI=10.1016/s0167-4781(98)00260-7;
RA   Adamski F.M., Timms K.M., Shieh B.H.;
RT   "A unique isoform of phospholipase Cbeta4 highly expressed in the
RT   cerebellum and eye.";
RL   Biochim. Biophys. Acta 1444:55-60(1999).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-886, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Activated phosphatidylinositol-specific phospholipase C
CC       enzymes catalyze the production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) involved in
CC       G-protein coupled receptor signaling pathways. PLCB4 is a direct
CC       effector of the endothelin receptor signaling pathway that plays an
CC       essential role in lower jaw and middle ear structures development (By
CC       similarity). {ECO:0000250|UniProtKB:Q07722,
CC       ECO:0000250|UniProtKB:Q15147}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-
CC         diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456,
CC         ChEBI:CHEBI:203600; EC=3.1.4.11;
CC         Evidence={ECO:0000250|UniProtKB:Q07722};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33180;
CC         Evidence={ECO:0000250|UniProtKB:Q07722};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O =
CC         1D-myo-inositol 1-phosphate + a 1,2-diacyl-sn-glycerol + H(+);
CC         Xref=Rhea:RHEA:43484, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:57880, ChEBI:CHEBI:58433;
CC         Evidence={ECO:0000250|UniProtKB:Q07722};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43485;
CC         Evidence={ECO:0000250|UniProtKB:Q07722};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q15147}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A;
CC         IsoId=Q9QW07-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9QW07-2; Sequence=VSP_004724, VSP_004725;
CC       Name=C;
CC         IsoId=Q9QW07-3; Sequence=VSP_004726;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in the retina.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L15556; AAK13557.1; -; mRNA.
DR   EMBL; U57836; AAD10403.1; -; mRNA.
DR   EMBL; AF031370; AAC98145.1; -; mRNA.
DR   EMBL; AF027571; AAC24984.1; -; mRNA.
DR   PIR; A48047; A48047.
DR   RefSeq; NP_077329.1; NM_024353.1.
DR   AlphaFoldDB; Q9QW07; -.
DR   SMR; Q9QW07; -.
DR   IntAct; Q9QW07; 2.
DR   STRING; 10116.ENSRNOP00000045972; -.
DR   iPTMnet; Q9QW07; -.
DR   PhosphoSitePlus; Q9QW07; -.
DR   jPOST; Q9QW07; -.
DR   PaxDb; 10116-ENSRNOP00000045972; -.
DR   GeneID; 25031; -.
DR   KEGG; rno:25031; -.
DR   UCSC; RGD:3345; rat. [Q9QW07-1]
DR   AGR; RGD:3345; -.
DR   CTD; 5332; -.
DR   RGD; 3345; Plcb4.
DR   eggNOG; KOG1265; Eukaryota.
DR   InParanoid; Q9QW07; -.
DR   BRENDA; 3.1.4.11; 5301.
DR   Reactome; R-RNO-112043; PLC beta mediated events.
DR   Reactome; R-RNO-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:Q9QW07; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IPI:RGD.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IBA:GO_Central.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IMP:RGD.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; IBA:GO_Central.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IBA:GO_Central.
DR   GO; GO:0160135; P:phospholipase C-activating endothelin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007602; P:phototransduction; NAS:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IBA:GO_Central.
DR   CDD; cd00275; C2_PLC_like; 1.
DR   CDD; cd16211; EFh_PI-PLCbeta4; 1.
DR   CDD; cd13361; PH_PLC_beta; 1.
DR   CDD; cd08591; PI-PLCc_beta; 1.
DR   Gene3D; 2.30.29.240; -; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 3.20.20.190; Phosphatidylinositol (PI) phosphodiesterase; 1.
DR   Gene3D; 1.20.1230.10; Phospholipase C beta, distal C-terminal domain; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016280; PLC-beta.
DR   InterPro; IPR014815; PLC-beta_C.
DR   InterPro; IPR042531; PLC-beta_C_sf.
DR   InterPro; IPR037862; PLC-beta_PH.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR053945; PLCB1-4-like_EFh.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336:SF211; 1-PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-4; 1.
DR   PANTHER; PTHR10336; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C FAMILY PROTEIN; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF17787; PH_14; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   Pfam; PF08703; PLC-beta_C; 1.
DR   Pfam; PF22631; PLCB1-4-like_EFh; 1.
DR   PIRSF; PIRSF000956; PLC-beta; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF69989; C-terminal domain of PLC-beta; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF51695; PLC-like phosphodiesterases; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Calcium; Cell membrane; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Phosphoprotein;
KW   Reference proteome; Transducer.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q15147"
FT   CHAIN           2..1175
FT                   /note="1-phosphatidylinositol 4,5-bisphosphate
FT                   phosphodiesterase beta-4"
FT                   /id="PRO_0000088496"
FT   DOMAIN          313..463
FT                   /note="PI-PLC X-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   DOMAIN          565..681
FT                   /note="PI-PLC Y-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00271"
FT   DOMAIN          684..809
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          487..512
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          860..904
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1082..1110
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        492..507
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        882..903
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1093..1110
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        328
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   ACT_SITE        375
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15147"
FT   MOD_RES         886
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1013..1022
FT                   /note="VKEIVAQHTK -> GKQRDASPSG (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:7688223"
FT                   /id="VSP_004724"
FT   VAR_SEQ         1023..1175
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:7688223"
FT                   /id="VSP_004725"
FT   VAR_SEQ         1154..1175
FT                   /note="AKEMQQMVKLEAEMDRRPATVV -> LLKSCHAVSQTQGEGDAADGEIGSRD
FT                   GPQTSNSSMKLQNAN (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:9931434"
FT                   /id="VSP_004726"
FT   CONFLICT        255
FT                   /note="L -> M (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308
FT                   /note="R -> A (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        417
FT                   /note="Q -> E (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        470
FT                   /note="E -> K (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        504
FT                   /note="A -> AA (in Ref. 1; AAK13557)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        545..546
FT                   /note="EQ -> DE (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        734
FT                   /note="I -> L (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        741
FT                   /note="R -> H (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        764
FT                   /note="L -> M (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        776
FT                   /note="D -> N (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        828
FT                   /note="F -> L (in Ref. 1; AAK13557)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        843
FT                   /note="S -> Y (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        852
FT                   /note="L -> M (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        916
FT                   /note="Q -> T (in Ref. 2; AAD10403/AAC98145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1024
FT                   /note="W -> C (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1043
FT                   /note="L -> M (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1057
FT                   /note="A -> V (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1067
FT                   /note="L -> V (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1084
FT                   /note="S -> C (in Ref. 3; AAC24984)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1175 AA;  134497 MW;  7379C6BB95B8FCED CRC64;
     MAKPYEFNWQ KEVPSFLQEG AVFDRYEEES FVFEPNCLFK VDEFGFFLTW KSEGKEGQVL
     ECSLINSIRL AAIPKDPKIL AALESVGKSE NDLEGRILCV CSGTDLVNIG FTYMVAENPE
     ITKQWVEGLR SIIHNFRANN VSPMTCLKKH WMKLAFLTNT SGKIPVRSIT RTFASGKTEK
     VIFQALKELG LPSGKNDEIE PAAFTYEKFY ELTQKICPRT DIEDLFKKIN GDKTDYLTVD
     QLVSFLNEHQ RDPRLNEILF PFYDAKRAMQ IIEMYEPDEE LKKKGLISSD GFCRYLMSDE
     NAPVFLDRLE LYQEMDHPLA HYFISSSHNT YLTGRQFGGK SSVEMYRQVL LAGCRCVELD
     CWDGKGEDQE PIITHGKAMC TDILFKDVIQ AIKETAFVTS EYPVILSFEN HCSKYQQYQM
     SKYCEDLFGD LLLKQALESH PLEPGRLLPS PNDLKRKILI KNKRLKPEVE KKQLEALKSM
     MEAGESAAPA SILEDDNEEE IESADQEEEA HPEYKFGNEL SADDFSHKEA VANSVKKGLV
     TVEDEQAWMA SYKYVGATTN IHPYLSTMIN YAQPVKFQGF HVAEERNIHY NMSSFNESVG
     LGYLKTHAIE FVNYNKRQMS RIYPKGGRVD SSNYMPQIFW NAGCQMVSLN YQTPDLAMQL
     NQGKFEYNGS CGYLLKPDFM RRPDRTFDPF SETPVDGVIA ATCSVQVISG QFLSDKKIGT
     YVEVDMYGLP TDTIRKEFRT RMVMNNGLNP VYNEESFVFR KVILPDLAVL RIAVYDDNNK
     LIGQRILPLD GLQAGYRHIS LRNEGNKPLS LPTIFCNIVL KTYVPDGFGD IVDALSDPKK
     FLSITEKRAD QLRAMGIETS DIADVPSDTS KNDKKGKANP AKANVTPQSS SELRPTTTAA
     LGSGQEAKKG IELIPQVRIE DLKQMKAYLK HLKKQQKELN SLKKKHAKEH STMQKLHCTQ
     VDKIVAQYDK EKSTHEKILE KAMKKKGGSN CLEIKKETEI KIQTLTSDHK SKVKEIVAQH
     TKEWSEMINT HSAEEQEIRD LHLSQQCELL RKLLINAHEQ QTQQLKLSHD RESKEMRAHQ
     AKISMENSKA ISQDKSIKNK AERERRVREL NSSNTKKFLE ERKRLAMKQS KEMDQLKKVQ
     LEHLEFLEKQ NEQAKEMQQM VKLEAEMDRR PATVV
//
